COSM
Cosmos Health, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.33
+11.10%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- $20.9M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$0.10
- EPS estimate
- -$0.10
- Revenue actual
- $19.3M
- Revenue estimate
- $19.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -575.0%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$0.10 | -$0.10 | In line | $19.3M |
| May 21, 2026 | -$0.06 | -$0.06 | In line | $17.9M |
| Nov 14, 2025 | -$0.01 | -$0.17 | Miss -1600.00% | $17.1M |
| Aug 18, 2025 | $0.01 | -$0.06 | Miss -700.00% | $14.7M |
| May 15, 2025 | -$0.03 | $0.01 | Beat 133.33% | $13.7M |
| Nov 14, 2024 | -$0.11 | -$0.45 | Miss -309.09% | $12.4M |
| Aug 20, 2024 | -$0.14 | -$0.04 | Beat 71.43% | $13.2M |
| Nov 21, 2023 | — | -$0.09 | — | $12.8M |
| Aug 15, 2023 | — | $0.02 | — | $12.4M |
| May 16, 2023 | — | -$0.04 | — | $12.3M |
| Mar 6, 2023 | — | -$2.15 | — | $16.2M |
| Nov 14, 2022 | — | -$2.00 | — | $12.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026